Skip navigation

Refine by Type

Results 1 - 6 of 6 for Dalfampridine
  1. Dalfampridine is used to improve walking in people who have multiple sclerosis (MS; a disease in which ... and problems with vision, speech, and bladder control). Dalfampridine may be used alone or with other medications ...
  2. Gait or Walking Problems (National Multiple Sclerosis Society) - PDF  
    ... national MSsociety.org/ampyra Medication sheet nationalMSsociety.org/dalfampridine ampyra is a trademark of acorda therapeutics. botox ...
  3. Index to Drug-Specific Information (Food and Drug Administration)  
    ... Amiodarone Amiodarone/Simvastatin Amnesteem (isotretinoin) Amphetamine salts Ampyra (dalfampridine) Amturnide (aliskiren/amlodipine/ hydrochlorothiazide) Anaprox (naproxen sodium) AndroGel ...
  4. Multiple Sclerosis: Hope through Research From the National Institutes of Health (National Institute of Neurological Disorders and Stroke)  
    ... cases. In 2010, the FDA approved the drug dalfampridine to improve walking in patients with MS. It ... use. Clinical trials showed that patients treated with dalfampridine had faster walking speeds than those treated with ...
  5. Multiple Sclerosis Interactive Tutorial (Patient Education Institute)  
    ... treatment for MS. The FDA has also approved dalfampridine (Ampyra®) to improve walking in individuals with MS. ...
  6. Multiple Sclerosis From the National Institutes of Health (National Institute of Neurological Disorders and Stroke) - Short Summary  
    ... or chronic MS. The FDA has also approved dalfampridine (Ampyra) to improve walking in individuals with MS. ...